APO Research
Talk to an analyst

APO RESEARCH · REPORT

Contraceptive Drug Eluting Devices

Compare research editions
View pricing & licenses

Selected research

Industry Research

Contraceptive Drug Eluting Devices Industry Research Report 2026

27 December 2025139 pages

Choose your research edition.

Industry ResearchContraceptive Drug Eluting Devices Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Contraceptive Drug Eluting Devices Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Contraceptive Drug Eluting Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Contraceptive Drug Eluting Devices Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Contraceptive Drug Eluting Devices Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Contraceptive Drug Eluting Devices market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Contraceptive Drug Eluting Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Contraceptive Drug Eluting Devices is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Contraceptive Drug Eluting Devices is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Contraceptive Drug Eluting Devices include CooperSurgical, Egemen International, ERENLER MEDIKAL, Gyneas, Laboratoire CCD, Medical Engineering Corporation, Melbea, Meril Life Sciences and Mona Lisa, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Contraceptive Drug Eluting Devices market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Contraceptive Drug Eluting Devices Market by Company

CooperSurgical

Egemen International

ERENLER MEDIKAL

Gyneas

Laboratoire CCD

Medical Engineering Corporation

Melbea

Meril Life Sciences

Mona Lisa

Pregna

Pregna International

Prosan International

Rongbo Medical

SMB Corporation of India

AbbVie

Bayer

Contraceptive Drug Eluting Devices Segment by Type

Non-biodegradable

Biodegradable

Contraceptive Drug Eluting Devices Segment by Application

Subcutaneously

Uterus

Contraceptive Drug Eluting Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contraceptive Drug Eluting Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Contraceptive Drug Eluting Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contraceptive Drug Eluting Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Contraceptive Drug Eluting Devices manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Contraceptive Drug Eluting Devices by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Contraceptive Drug Eluting Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Contraceptive Drug Eluting Devices Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Contraceptive Drug Eluting Devices Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Contraceptive Drug Eluting Devices Sales Market Share by Manufacturers (2021-2026) Table 8. Global Contraceptive Drug Eluting Devices Revenue of Manufacturers (2021-2026) Table 9. Global Contraceptive Drug Eluting Devices Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Contraceptive Drug Eluting Devices Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Contraceptive Drug Eluting Devices Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Contraceptive Drug Eluting Devices, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Contraceptive Drug Eluting Devices, Product Type & Application Table 14. Global Contraceptive Drug Eluting Devices Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Contraceptive Drug Eluting Devices by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. CooperSurgical Company Information Table 19. CooperSurgical Business Overview Table 20. CooperSurgical Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. CooperSurgical Contraceptive Drug Eluting Devices Product Portfolio Table 22. CooperSurgical Recent Developments Table 23. Egemen International Company Information Table 24. Egemen International Business Overview Table 25. Egemen International Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Egemen International Contraceptive Drug Eluting Devices Product Portfolio Table 27. Egemen International Recent Developments Table 28. ERENLER MEDIKAL Company Information Table 29. ERENLER MEDIKAL Business Overview Table 30. ERENLER MEDIKAL Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. ERENLER MEDIKAL Contraceptive Drug Eluting Devices Product Portfolio Table 32. ERENLER MEDIKAL Recent Developments Table 33. Gyneas Company Information Table 34. Gyneas Business Overview Table 35. Gyneas Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Gyneas Contraceptive Drug Eluting Devices Product Portfolio Table 37. Gyneas Recent Developments Table 38. Laboratoire CCD Company Information Table 39. Laboratoire CCD Business Overview Table 40. Laboratoire CCD Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Laboratoire CCD Contraceptive Drug Eluting Devices Product Portfolio Table 42. Laboratoire CCD Recent Developments Table 43. Medical Engineering Corporation Company Information Table 44. Medical Engineering Corporation Business Overview Table 45. Medical Engineering Corporation Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Medical Engineering Corporation Contraceptive Drug Eluting Devices Product Portfolio Table 47. Medical Engineering Corporation Recent Developments Table 48. Melbea Company Information Table 49. Melbea Business Overview Table 50. Melbea Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Melbea Contraceptive Drug Eluting Devices Product Portfolio Table 52. Melbea Recent Developments Table 53. Meril Life Sciences Company Information Table 54. Meril Life Sciences Business Overview Table 55. Meril Life Sciences Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Meril Life Sciences Contraceptive Drug Eluting Devices Product Portfolio Table 57. Meril Life Sciences Recent Developments Table 58. Mona Lisa Company Information Table 59. Mona Lisa Business Overview Table 60. Mona Lisa Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Mona Lisa Contraceptive Drug Eluting Devices Product Portfolio Table 62. Mona Lisa Recent Developments Table 63. Pregna Company Information Table 64. Pregna Business Overview Table 65. Pregna Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Pregna Contraceptive Drug Eluting Devices Product Portfolio Table 67. Pregna Recent Developments Table 68. Pregna International Company Information Table 69. Pregna International Business Overview Table 70. Pregna International Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Pregna International Contraceptive Drug Eluting Devices Product Portfolio Table 72. Pregna International Recent Developments Table 73. Prosan International Company Information Table 74. Prosan International Business Overview Table 75. Prosan International Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Prosan International Contraceptive Drug Eluting Devices Product Portfolio Table 77. Prosan International Recent Developments Table 78. Rongbo Medical Company Information Table 79. Rongbo Medical Business Overview Table 80. Rongbo Medical Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Rongbo Medical Contraceptive Drug Eluting Devices Product Portfolio Table 82. Rongbo Medical Recent Developments Table 83. SMB Corporation of India Company Information Table 84. SMB Corporation of India Business Overview Table 85. SMB Corporation of India Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. SMB Corporation of India Contraceptive Drug Eluting Devices Product Portfolio Table 87. SMB Corporation of India Recent Developments Table 88. AbbVie Company Information Table 89. AbbVie Business Overview Table 90. AbbVie Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. AbbVie Contraceptive Drug Eluting Devices Product Portfolio Table 92. AbbVie Recent Developments Table 93. Bayer Company Information Table 94. Bayer Business Overview Table 95. Bayer Contraceptive Drug Eluting Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Bayer Contraceptive Drug Eluting Devices Product Portfolio Table 97. Bayer Recent Developments Table 98. Global Contraceptive Drug Eluting Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 99. Global Contraceptive Drug Eluting Devices Sales by Region (2021-2026) & (K Units) Table 100. Global Contraceptive Drug Eluting Devices Sales Market Share by Region (2021-2026) Table 101. Global Contraceptive Drug Eluting Devices Sales by Region (2027-2032) & (K Units) Table 102. Global Contraceptive Drug Eluting Devices Sales Market Share by Region (2027-2032) Table 103. Global Contraceptive Drug Eluting Devices Revenue by Region (2021-2026) & (US$ Million) Table 104. Global Contraceptive Drug Eluting Devices Revenue Market Share by Region (2021-2026) Table 105. Global Contraceptive Drug Eluting Devices Revenue by Region (2027-2032) & (US$ Million) Table 106. Global Contraceptive Drug Eluting Devices Revenue Market Share by Region (2027-2032) Table 107. North America Contraceptive Drug Eluting Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. North America Contraceptive Drug Eluting Devices Sales by Country (2021-2026) & (K Units) Table 109. North America Contraceptive Drug Eluting Devices Sales by Country (2027-2032) & (K Units) Table 110. North America Contraceptive Drug Eluting Devices Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Contraceptive Drug Eluting Devices Revenue by Country (2027-2032) & (US$ Million) Table 112. Europe Contraceptive Drug Eluting Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Europe Contraceptive Drug Eluting Devices Sales by Country (2021-2026) & (K Units) Table 114. Europe Contraceptive Drug Eluting Devices Sales by Country (2027-2032) & (K Units) Table 115. Europe Contraceptive Drug Eluting Devices Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Contraceptive Drug Eluting Devices Revenue by Country (2027-2032) & (US$ Million) Table 117. Asia Pacific Contraceptive Drug Eluting Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Asia Pacific Contraceptive Drug Eluting Devices Sales by Country (2021-2026) & (K Units) Table 119. Asia Pacific Contraceptive Drug Eluting Devices Sales by Country (2027-2032) & (K Units) Table 120. Asia Pacific Contraceptive Drug Eluting Devices Revenue by Country (2021-2026) & (US$ Million) Table 121. Asia Pacific Contraceptive Drug Eluting Devices Revenue by Country (2027-2032) & (US$ Million) Table 122. South America Contraceptive Drug Eluting Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. South America Contraceptive Drug Eluting Devices Sales by Country (2021-2026) & (K Units) Table 124. South America Contraceptive Drug Eluting Devices Sales by Country (2027-2032) & (K Units) Table 125. South America Contraceptive Drug Eluting Devices Revenue by Country (2021-2026) & (US$ Million) Table 126. South America Contraceptive Drug Eluting Devices Revenue by Country (2027-2032) & (US$ Million) Table 127. Middle East and Africa Contraceptive Drug Eluting Devices Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Middle East and Africa Contraceptive Drug Eluting Devices Sales by Country (2021-2026) & (K Units) Table 129. Middle East and Africa Contraceptive Drug Eluting Devices Sales by Country (2027-2032) & (K Units) Table 130. Middle East and Africa Contraceptive Drug Eluting Devices Revenue by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa Contraceptive Drug Eluting Devices Revenue by Country (2027-2032) & (US$ Million) Table 132. Global Contraceptive Drug Eluting Devices Sales by Type (2021-2026) & (K Units) Table 133. Global Contraceptive Drug Eluting Devices Sales by Type (2027-2032) & (K Units) Table 134. Global Contraceptive Drug Eluting Devices Sales Market Share by Type (2021-2026) Table 135. Global Contraceptive Drug Eluting Devices Sales Market Share by Type (2027-2032) Table 136. Global Contraceptive Drug Eluting Devices Revenue by Type (2021-2026) & (US$ Million) Table 137. Global Contraceptive Drug Eluting Devices Revenue by Type (2027-2032) & (US$ Million) Table 138. Global Contraceptive Drug Eluting Devices Revenue Market Share by Type (2021-2026) Table 139. Global Contraceptive Drug Eluting Devices Revenue Market Share by Type (2027-2032) Table 140. Global Contraceptive Drug Eluting Devices Price by Type (2021-2026) & (US$/Unit) Table 141. Global Contraceptive Drug Eluting Devices Price by Type (2027-2032) & (US$/Unit) Table 142. Global Contraceptive Drug Eluting Devices Sales by Application (2021-2026) & (K Units) Table 143. Global Contraceptive Drug Eluting Devices Sales by Application (2027-2032) & (K Units) Table 144. Global Contraceptive Drug Eluting Devices Sales Market Share by Application (2021-2026) Table 145. Global Contraceptive Drug Eluting Devices Sales Market Share by Application (2027-2032) Table 146. Global Contraceptive Drug Eluting Devices Revenue by Application (2021-2026) & (US$ Million) Table 147. Global Contraceptive Drug Eluting Devices Revenue by Application (2027-2032) & (US$ Million) Table 148. Global Contraceptive Drug Eluting Devices Revenue Market Share by Application (2021-2026) Table 149. Global Contraceptive Drug Eluting Devices Revenue Market Share by Application (2027-2032) Table 150. Global Contraceptive Drug Eluting Devices Price by Application (2021-2026) & (US$/Unit) Table 151. Global Contraceptive Drug Eluting Devices Price by Application (2027-2032) & (US$/Unit) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Contraceptive Drug Eluting Devices Distributors List Table 155. Contraceptive Drug Eluting Devices Customers List Table 156. Contraceptive Drug Eluting Devices Industry Trends Table 157. Contraceptive Drug Eluting Devices Industry Drivers Table 158. Contraceptive Drug Eluting Devices Industry Restraints Table 159. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Contraceptive Drug Eluting Devices Product Image Figure 5. Global Contraceptive Drug Eluting Devices Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Contraceptive Drug Eluting Devices Market Size (2021-2032) & (US$ Million) Figure 7. Global Contraceptive Drug Eluting Devices Sales (2021-2032) & (K Units) Figure 8. Global Contraceptive Drug Eluting Devices Average Price (US$/Unit) & (2021-2032) Figure 9. Non-biodegradable Product Image Figure 10. Biodegradable Product Image Figure 11. Subcutaneously Product Image Figure 12. Uterus Product Image Figure 13. Global Contraceptive Drug Eluting Devices Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Contraceptive Drug Eluting Devices, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Contraceptive Drug Eluting Devices Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Contraceptive Drug Eluting Devices Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Contraceptive Drug Eluting Devices Sales by Region in 2025 Figure 19. Global Contraceptive Drug Eluting Devices Revenue by Region in 2025 Figure 20. North America Contraceptive Drug Eluting Devices Market Size by Country in 2025 Figure 21. North America Contraceptive Drug Eluting Devices Sales Market Share by Country (2021-2032) Figure 22. North America Contraceptive Drug Eluting Devices Revenue Market Share by Country (2021-2032) Figure 23. United States Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Mexico Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Europe Contraceptive Drug Eluting Devices Market Size by Country in 2025 Figure 27. Europe Contraceptive Drug Eluting Devices Sales Market Share by Country (2021-2032) Figure 28. Europe Contraceptive Drug Eluting Devices Revenue Market Share by Country (2021-2032) Figure 29. Germany Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. France Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. U.K. Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Italy Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Russia Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Spain Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Netherlands Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Switzerland Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Sweden Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Poland Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Contraceptive Drug Eluting Devices Market Size by Country in 2025 Figure 40. Asia Pacific Contraceptive Drug Eluting Devices Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Contraceptive Drug Eluting Devices Revenue Market Share by Country (2021-2032) Figure 42. China Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Taiwan Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Contraceptive Drug Eluting Devices Market Size by Country in 2025 Figure 51. South America Contraceptive Drug Eluting Devices Sales Market Share by Country (2021-2032) Figure 52. South America Contraceptive Drug Eluting Devices Revenue Market Share by Country (2021-2032) Figure 53. Brazil Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Chile Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Contraceptive Drug Eluting Devices Market Size by Country in 2025 Figure 57. Middle East and Africa Contraceptive Drug Eluting Devices Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Contraceptive Drug Eluting Devices Revenue Market Share by Country (2021-2032) Figure 59. Egypt Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. South Africa Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Israel Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Türkiye Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. GCC Countries Contraceptive Drug Eluting Devices Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Global Contraceptive Drug Eluting Devices Sales Market Share by Type (2021-2032) Figure 65. Global Contraceptive Drug Eluting Devices Revenue Market Share by Type (2021-2032) Figure 66. Global Contraceptive Drug Eluting Devices Price (US$/Unit) by Type (2021-2032) Figure 67. Global Contraceptive Drug Eluting Devices Sales Market Share by Application (2021-2032) Figure 68. Global Contraceptive Drug Eluting Devices Revenue Market Share by Application (2021-2032) Figure 69. Global Contraceptive Drug Eluting Devices Price (US$/Unit) by Application (2021-2032) Figure 70. Contraceptive Drug Eluting Devices Value Chain Figure 71. Contraceptive Drug Eluting Devices Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Contraceptive Drug Eluting Devices Industry Opportunities and Challenges

Scope & coverage.

Types
  • Non-biodegradable
  • Biodegradable
Applications
  • Subcutaneously
  • Uterus
Companies covered
  • CooperSurgical
  • Egemen International
  • ERENLER MEDIKAL
  • Gyneas
  • Laboratoire CCD
  • Medical Engineering Corporation
  • Melbea
  • Meril Life Sciences
  • Mona Lisa
  • Pregna
  • Pregna International
  • Prosan International
  • Rongbo Medical
  • SMB Corporation of India
  • AbbVie
  • Bayer

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Contraceptive Drug Eluting Devices Market Size (2021-2032)
  4. 2.2.2 Global Contraceptive Drug Eluting Devices Sales (2021-2032)
  5. 2.2.3 Global Contraceptive Drug Eluting Devices Market Average Price (2021-2032)
  6. 2.3 Contraceptive Drug Eluting Devices by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Non-biodegradable
  9. 2.3.3 Biodegradable
  10. 2.4 Contraceptive Drug Eluting Devices by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Subcutaneously
  13. 2.4.3 Uterus
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Contraceptive Drug Eluting Devices Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Contraceptive Drug Eluting Devices Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Contraceptive Drug Eluting Devices Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Contraceptive Drug Eluting Devices Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Contraceptive Drug Eluting Devices Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Contraceptive Drug Eluting Devices, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Contraceptive Drug Eluting Devices, Product Type & Application
  8. 3.8 Global Manufacturers of Contraceptive Drug Eluting Devices, Established Date
  9. 3.9 Global Contraceptive Drug Eluting Devices Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 CooperSurgical
  2. 4.1.1 CooperSurgical Company Information
  3. 4.1.2 CooperSurgical Business Overview
  4. 4.1.3 CooperSurgical Contraceptive Drug Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 CooperSurgical Contraceptive Drug Eluting Devices Product Portfolio
  6. 4.1.5 CooperSurgical Recent Developments
  7. 4.2 Egemen International
  8. 4.2.1 Egemen International Company Information
  9. 4.2.2 Egemen International Business Overview
  10. 4.2.3 Egemen International Contraceptive Drug Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Egemen International Contraceptive Drug Eluting Devices Product Portfolio
  12. 4.2.5 Egemen International Recent Developments
  13. 4.3 ERENLER MEDIKAL
  14. 4.3.1 ERENLER MEDIKAL Company Information
  15. 4.3.2 ERENLER MEDIKAL Business Overview
  16. 4.3.3 ERENLER MEDIKAL Contraceptive Drug Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 ERENLER MEDIKAL Contraceptive Drug Eluting Devices Product Portfolio
  18. 4.3.5 ERENLER MEDIKAL Recent Developments
  19. 4.4 Gyneas
  20. 4.4.1 Gyneas Company Information
  21. 4.4.2 Gyneas Business Overview
  22. 4.4.3 Gyneas Contraceptive Drug Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Gyneas Contraceptive Drug Eluting Devices Product Portfolio
  24. 4.4.5 Gyneas Recent Developments
  25. 4.5 Laboratoire CCD
  26. 4.5.1 Laboratoire CCD Company Information
  27. 4.5.2 Laboratoire CCD Business Overview
  28. 4.5.3 Laboratoire CCD Contraceptive Drug Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Laboratoire CCD Contraceptive Drug Eluting Devices Product Portfolio
  30. 4.5.5 Laboratoire CCD Recent Developments
  31. 4.6 Medical Engineering Corporation
  32. 4.6.1 Medical Engineering Corporation Company Information
  33. 4.6.2 Medical Engineering Corporation Business Overview
  34. 4.6.3 Medical Engineering Corporation Contraceptive Drug Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Medical Engineering Corporation Contraceptive Drug Eluting Devices Product Portfolio
  36. 4.6.5 Medical Engineering Corporation Recent Developments
  37. 4.7 Melbea
  38. 4.7.1 Melbea Company Information
  39. 4.7.2 Melbea Business Overview
  40. 4.7.3 Melbea Contraceptive Drug Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Melbea Contraceptive Drug Eluting Devices Product Portfolio
  42. 4.7.5 Melbea Recent Developments
  43. 4.8 Meril Life Sciences
  44. 4.8.1 Meril Life Sciences Company Information
  45. 4.8.2 Meril Life Sciences Business Overview
  46. 4.8.3 Meril Life Sciences Contraceptive Drug Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Meril Life Sciences Contraceptive Drug Eluting Devices Product Portfolio
  48. 4.8.5 Meril Life Sciences Recent Developments
  49. 4.9 Mona Lisa
  50. 4.9.1 Mona Lisa Company Information
  51. 4.9.2 Mona Lisa Business Overview
  52. 4.9.3 Mona Lisa Contraceptive Drug Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Mona Lisa Contraceptive Drug Eluting Devices Product Portfolio
  54. 4.9.5 Mona Lisa Recent Developments
  55. 4.10 Pregna
  56. 4.10.1 Pregna Company Information
  57. 4.10.2 Pregna Business Overview
  58. 4.10.3 Pregna Contraceptive Drug Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Pregna Contraceptive Drug Eluting Devices Product Portfolio
  60. 4.10.5 Pregna Recent Developments
  61. 4.11 Pregna International
  62. 4.11.1 Pregna International Company Information
  63. 4.11.2 Pregna International Business Overview
  64. 4.11.3 Pregna International Contraceptive Drug Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Pregna International Contraceptive Drug Eluting Devices Product Portfolio
  66. 4.11.5 Pregna International Recent Developments
  67. 4.12 Prosan International
  68. 4.12.1 Prosan International Company Information
  69. 4.12.2 Prosan International Business Overview
  70. 4.12.3 Prosan International Contraceptive Drug Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Prosan International Contraceptive Drug Eluting Devices Product Portfolio
  72. 4.12.5 Prosan International Recent Developments
  73. 4.13 Rongbo Medical
  74. 4.13.1 Rongbo Medical Company Information
  75. 4.13.2 Rongbo Medical Business Overview
  76. 4.13.3 Rongbo Medical Contraceptive Drug Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Rongbo Medical Contraceptive Drug Eluting Devices Product Portfolio
  78. 4.13.5 Rongbo Medical Recent Developments
  79. 4.14 SMB Corporation of India
  80. 4.14.1 SMB Corporation of India Company Information
  81. 4.14.2 SMB Corporation of India Business Overview
  82. 4.14.3 SMB Corporation of India Contraceptive Drug Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 SMB Corporation of India Contraceptive Drug Eluting Devices Product Portfolio
  84. 4.14.5 SMB Corporation of India Recent Developments
  85. 4.15 AbbVie
  86. 4.15.1 AbbVie Company Information
  87. 4.15.2 AbbVie Business Overview
  88. 4.15.3 AbbVie Contraceptive Drug Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 AbbVie Contraceptive Drug Eluting Devices Product Portfolio
  90. 4.15.5 AbbVie Recent Developments
  91. 4.16 Bayer
  92. 4.16.1 Bayer Company Information
  93. 4.16.2 Bayer Business Overview
  94. 4.16.3 Bayer Contraceptive Drug Eluting Devices Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Bayer Contraceptive Drug Eluting Devices Product Portfolio
  96. 4.16.5 Bayer Recent Developments
5 Global Contraceptive Drug Eluting Devices Market Scenario by Region
  1. 5.1 Global Contraceptive Drug Eluting Devices Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Contraceptive Drug Eluting Devices Sales by Region: 2021-2032
  3. 5.2.1 Global Contraceptive Drug Eluting Devices Sales by Region: 2021-2026
  4. 5.2.2 Global Contraceptive Drug Eluting Devices Sales by Region: 2027-2032
  5. 5.3 Global Contraceptive Drug Eluting Devices Revenue by Region: 2021-2032
  6. 5.3.1 Global Contraceptive Drug Eluting Devices Revenue by Region: 2021-2026
  7. 5.3.2 Global Contraceptive Drug Eluting Devices Revenue by Region: 2027-2032
  8. 5.4 North America Contraceptive Drug Eluting Devices Market Facts & Figures by Country
  9. 5.4.1 North America Contraceptive Drug Eluting Devices Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Contraceptive Drug Eluting Devices Sales by Country (2021-2032)
  11. 5.4.3 North America Contraceptive Drug Eluting Devices Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Contraceptive Drug Eluting Devices Market Facts & Figures by Country
  16. 5.5.1 Europe Contraceptive Drug Eluting Devices Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Contraceptive Drug Eluting Devices Sales by Country (2021-2032)
  18. 5.5.3 Europe Contraceptive Drug Eluting Devices Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Contraceptive Drug Eluting Devices Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Contraceptive Drug Eluting Devices Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Contraceptive Drug Eluting Devices Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Contraceptive Drug Eluting Devices Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Contraceptive Drug Eluting Devices Market Facts & Figures by Country
  41. 5.7.1 South America Contraceptive Drug Eluting Devices Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Contraceptive Drug Eluting Devices Sales by Country (2021-2032)
  43. 5.7.3 South America Contraceptive Drug Eluting Devices Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Contraceptive Drug Eluting Devices Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Contraceptive Drug Eluting Devices Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Contraceptive Drug Eluting Devices Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Contraceptive Drug Eluting Devices Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Contraceptive Drug Eluting Devices Sales by Type (2021-2032)
  2. 6.1.1 Global Contraceptive Drug Eluting Devices Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Contraceptive Drug Eluting Devices Sales Market Share by Type (2021-2032)
  4. 6.2 Global Contraceptive Drug Eluting Devices Revenue by Type (2021-2032)
  5. 6.2.1 Global Contraceptive Drug Eluting Devices Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Contraceptive Drug Eluting Devices Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Contraceptive Drug Eluting Devices Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Contraceptive Drug Eluting Devices Sales by Application (2021-2032)
  2. 7.1.1 Global Contraceptive Drug Eluting Devices Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Contraceptive Drug Eluting Devices Sales Market Share by Application (2021-2032)
  4. 7.2 Global Contraceptive Drug Eluting Devices Revenue by Application (2021-2032)
  5. 7.2.1 Global Contraceptive Drug Eluting Devices Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Contraceptive Drug Eluting Devices Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Contraceptive Drug Eluting Devices Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Contraceptive Drug Eluting Devices Value Chain Analysis
  2. 8.1.1 Contraceptive Drug Eluting Devices Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Contraceptive Drug Eluting Devices Production Mode & Process
  5. 8.2 Contraceptive Drug Eluting Devices Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Contraceptive Drug Eluting Devices Distributors
  8. 8.2.3 Contraceptive Drug Eluting Devices Customers
9 Global Contraceptive Drug Eluting Devices Analyzing Market Dynamics
  1. 9.1 Contraceptive Drug Eluting Devices Industry Trends
  2. 9.2 Contraceptive Drug Eluting Devices Industry Drivers
  3. 9.3 Contraceptive Drug Eluting Devices Industry Opportunities and Challenges
  4. 9.4 Contraceptive Drug Eluting Devices Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst